전임상 돼지 모델에서 장기 혈관 접근을 위한 Hickman 카테터 사용

Executive Industry Relevance

Reliable long-term vascular access in preclinical swine models is critical for translational studies requiring repeated blood sampling and intravenous dosing. The described Hickman catheter protocol addresses a key operational challenge by minimizing line-related complications, supporting uninterrupted data collection and study continuity. This capability enhances predictive confidence in large animal studies, directly impacting the quality of preclinical pharmacology and safety data.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables sustained access for serial biomarker sampling in disease-relevant large animal models.
• Supports longitudinal pharmacokinetic and pharmacodynamic studies with reduced procedural variability.
• Facilitates mechanistic de-risking by ensuring consistent sample integrity over extended study periods.

Screening & Assay Development

• Provides a validated vascular access platform for standardized compound administration and sampling.
• Improves reproducibility of in vivo assays by minimizing catheter-related interruptions.
• Enables scalable study designs by reducing line failure rates and associated downtime.

Translational & Preclinical Research

• Aligns with translational biomarker strategies by supporting high-frequency, low-stress sampling regimens.
• Maintains continuity from early discovery through preclinical validation by reducing animal morbidity and data loss.
• Decreases risk of confounding variables related to vascular access, strengthening preclinical evidence packages.

Pipeline & Workflow Integration

This protocol integrates into the preclinical workflow from early discovery through lead optimization, supporting both exploratory and regulatory-enabling studies in large animal models.

• Discovery Biology: Ensures reliable access for hypothesis-driven sampling and intervention studies.
• Screening: Standardizes compound delivery and sample collection for robust in vivo assay outputs.
• Analytics: Enables quantitative, longitudinal measurement of blood-based endpoints with minimal sample loss.
• Translational Research: Supports biomarker continuity and data integrity across study phases.
• Enterprise Reuse: Establishes a reproducible vascular access method adaptable to diverse large animal protocols.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces biological variability in preclinical studies.
• Operational Value: Enhances standardization, reproducibility, and scalability of large animal workflows.
• Strategic Value: Supports efficient go/no-go decisions by minimizing study delays and data gaps.
• Portfolio Impact: Enables risk-adjusted advancement by ensuring high-quality, uninterrupted data streams.

Implementation Considerations

• Requires surgical expertise in large animal vascular access and catheter placement.
• Needs appropriate instrumentation for catheter insertion, maintenance, and monitoring.
• Demands cross-team adherence to standardized maintenance and troubleshooting protocols.
• Adaptable to various swine models but may require protocol adjustments for other species.
• Potential limitations include the need for specialized protective devices and ongoing line surveillance.

Biopharma FAQs